<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=601572900419438&amp;ev=PageView&amp;noscript=1">
3
CELL LINE DEVELOPMENT
6
FORMULATION DEVELOPMENT
2
QUALITY & REGULATORY CMC SUPPORT
cGMP MANUFACTURING
5
ANALYTICAL METHODS DEVELOPMENT
4
PROCESS DEVELOPMENT (USP & DSP)

Flexible and Fast-Growing CDMO

Northway Biotech is a leading contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of biopharmaceuticals. The company’s wide-ranging expertise and vertically integrated service offering translate to the ability to rapidly execute multiple projects from its state-of-the-art cGMP facilities while ensuring full process and product compliance at all stages of research, development and commercial manufacturing.

Modern, Centrally-Located Facilities

Our state-of-the-art facilities in the EU and US include more than 40 R&D labs for CLD, USP, DSP, and analytical development, as well as cGMP manufacturing. Whether mammalian cell culture or microbial processing is optimal for your product's development, our cGMP facilities are equipped with separate production units to support the development and manufacturing of your drug substance and aseptic drug product.

facilities_final

October 18, 2024

The first Gene Therapy Centre in the Baltics was built and equipped by Lithuanians in just one year, and now plans are underway for an even more spectacular vision of BIO CITY

Read More

In the News

April 25, 2024

NIB and Citadele fund Baltics’ first gene therapy manufacturing facility

Read More

September 10, 2024

Professor V. A. Bumelis opens the Lithuanian Museum of Biotechnology

Read More

Upcoming Events

BIO-Europe 2024

November 4-6, 2024
Stockholm, Sweden
Booth 61

BMWS 2024

November 19-21, 2024
San Diego, CA
Booth 47

Contact Northway Biotech